Brief: Klaria Pharma Q1 Loss At SEK 20.3 Million
May 12 (Reuters) - Klaria Pharma Holding AB (publ)
KLAR.ST :
* Q1 LOSS AFTER TAX SEK -20.3 MILLION (SEK 16.7 MILLION)
* Q1 RESEARCH AND DEVELOPMENT EXPENSES FOR PERIOD SEK 17.1
MILLION
(SEK 11.4 MILLION)
Source text for Eikon: ID:nWkr66d0WT
Further company coverage: KLAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement